Post-acute COVID-19 condition in Saudi Arabia: A national representative study

被引:19
作者
AlRadini, Faten A. [1 ]
Alamri, Fahad [2 ]
Aljahany, Muna S. [1 ]
Almuzaini, Yasir
Alsofayan, Yousef [2 ]
Khan, Anas [3 ]
Albogami, Nada [4 ]
Abdulrahim, Maha [5 ]
Almogbil, Alanoud [6 ]
Alahmari, Ahmed
机构
[1] Princess Nourah bint Abdulrahman Univ, Coll Med, Dept Clin Sci, POB 84428, Riyadh 11671, Saudi Arabia
[2] Saudi Red Crescent Author, Gen Directorate Data & Res, Riyadh, Saudi Arabia
[3] King Saud Univ, Coll Med, Dept Emergency Med, Riyadh, Saudi Arabia
[4] Natl Secur Hosp, Dept Psychiat Med, Riyadh, Saudi Arabia
[5] Princess Nourah Bint Abdulrahman Univ, King Abdullah Bin Abdulaziz Univ Hosp, Res & Acad Accreditat Off, POB 84428, Riyadh 11671, Saudi Arabia
[6] Res Unit, Riyadh, Saudi Arabia
关键词
SARS-CoV-2; Late symptoms; Persistent symptoms; Post-acute COVID-19 condition;
D O I
10.1016/j.jiph.2022.03.013
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Many survivors of COVID-19 have developed symptoms and diseases similar to those observed after severe acute respiratory syndrome (SARS). Therefore, this study aimed to characterize the symptoms that appear after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been eradicated and to determine their relationship with COVID-19 severity. Methods: This multicenter, retrospective cross-sectional study was conducted in all eligible confirmed cases of SARS-CoV-2 infection from Saudi Arabia. Study participants were randomly selected using computerized random sampling from a population of 314,821 patients. Descriptive statistics were used to describe baseline demographic data and clinical characteristics. Categorical variables were presented as counts and percentages, while continuous variables were presented as means and standard deviations. Results: Approximately 70% of patients were found to have five or fewer symptoms simultaneously. Late symptoms (in the ongoing symptomatic COVID-19) occurred in 225 (22 center dot 5%) patients with the most common late symptoms being loss of smell, loss of taste, fatigue, shortness of breath, and cough (52 center dot 4%, 31 center dot 1%, 11 center dot 5%, 10 center dot 2%, and 8 center dot 9% of patients with late symptoms, respectively). We also found that the presence of acute symptoms of COVID19 and admission to the hospital were significant independent predictors of the post-COVID-19 condition. Conclusion: Saudi patients with COVID-19 develop a wide range of symptoms, similar to those observed and reported in other countries. The loss of smell, the loss of taste, shortness of breath, and fatigue were the main persistent symptoms. Regular follow-up of COVID-19 survivors is highly recommended to minimize the burden of the post-acute COVID-19 condition and improve the quality of life of patients. (c) 2022 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
引用
收藏
页码:526 / 532
页数:7
相关论文
共 25 条
[1]   A Clinical Review of COVID-19; Pathogenesis, Diagnosis, and Management [J].
Abdelgawad, Hussien Ahmed H. ;
Sayed, Ahmed ;
Munir, Malak ;
Elberry, Mostafa H. ;
Sayed, Ibrahim M. ;
Kamal, Md. Amjad ;
Negida, Ahmed ;
Ebada, Mahmoud A. ;
Bahbah, Eshak I. .
CURRENT PHARMACEUTICAL DESIGN, 2021, 27 (41) :4232-4244
[2]   The psychological impact of quarantine and how to reduce it: rapid review of the evidence [J].
Brooks, Samantha K. ;
Webster, Rebecca K. ;
Smith, Louise E. ;
Woodland, Lisa ;
Wessely, Simon ;
Greenberg, Neil ;
Rubin, Gideon James .
LANCET, 2020, 395 (10227) :912-920
[3]   Persistent Symptoms in Patients After Acute COVID-19 [J].
Carfi, Angelo ;
Bernabei, Roberto ;
Landi, Francesco .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (06) :603-605
[4]  
Centers for Disease Control and Prevention, 2021, C POST COVID COND
[5]  
Centers for Disease Control and Prevention CDC, 2021, SARS COV 2 VAR CLASS
[6]   A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection Illness Beyond Acute Infection and Public Health Implications [J].
Datta, S. Deblina ;
Talwar, Amish ;
Lee, James T. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (22) :2251-2252
[7]   Long-term Health Consequences of COVID-19 [J].
del Rio, Carlos ;
Collins, Lauren F. ;
Malani, Preeti .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (17) :1723-1724
[8]  
Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI [10.1128/CMR.00028-20, 10.1038/s41432-020-0088-4]
[9]  
Ebada Mahmoud Ahmed, 2021, Infectious Disorders - Drug Targets, V21, pe160921189190, DOI 10.2174/1871526520666201216165322
[10]   Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? [J].
Goertz, Yvonne M. J. ;
Van Herck, Maarten ;
Delbressine, Jeannet M. ;
Vaes, Anouk W. ;
Meys, Roy ;
Machado, Felipe V. C. ;
Houben-Wilke, Sarah ;
Burtin, Chris ;
Posthuma, Rein ;
Franssen, Frits M. E. ;
van Loon, Nicole ;
Hajian, Bita ;
Spies, Yvonne ;
Vijlbrief, Herman ;
van't Hul, Alex J. ;
Janssen, Daisy J. A. ;
Spruit, Martijn A. .
ERJ OPEN RESEARCH, 2020, 6 (04) :1-10